FONR Fonar Corporation ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS Best Electromedical Stocks 2026 →

Fonar (FONR) Stock: Buy, Sell, or Hold?

$19.09
-0.02 (-0.10%) â–ŧ
5d: +0.95% 30d: +0.85% 90d: +3.19%
Open in Live Scanner Earnings: May 21, 2026 0d Updated Jun 2, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (79%)
Quality Score
46/100
Position
FAIR
Forward P/E & Valuation
10.9x
Next 12M consensus est.
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$18.84 / $19.16
Trend: Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
â„šī¸ NEUTRAL: FONR is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.

Get Alerted When FONR Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: FONR is currently trading at $19.09, which is considered fair based on recent price action.

Technical Outlook: Technically, FONR is in a uptrend. The price is currently testing key support at $18.84. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: FONR scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Company Quality Score 46/100 (HOLD)
Volume Confirmation UNKNOWN
Confidence Score 79.4%

Trading Range & Key Levels

Support Level $18.84
Resistance Level $19.16
Current Trend Uptrend
Technical data as of Jun 2, 2026

Quantitative Signal Breakdown

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (60/100)
  • WARNING: Composite score 46/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) 10.88
Revenue Growth (YoY) -2.6%
Earnings Growth (YoY) -37.1%
Profit Margin 6.3%
Share FONR Analysis

Share this live FONR analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.
Last updated: November 10, 2026 9:36 PM ET
Data refreshes hourly during market hours. Next update: 10:36 PM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for FONR.

Create Free Account

Already have an account? Log In

Top Rated Diagnostics & Research Stocks

Top-rated stocks in Diagnostics & Research by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
GH
Guardant Health Inc
STRONG BUY
26 analysts
$201 52 HOLD
TMO
Thermo Fisher Scientificâ€Ļ
STRONG BUY
27 analysts
$752 54 HOLD
EXAS
EXACT Sciences Corporatiâ€Ļ
STRONG BUY
26 analysts
$106 52 HOLD
NTRA
Natera Inc
STRONG BUY
23 analysts
$416 58 HOLD
DHR
Danaher Corporation
STRONG BUY
24 analysts
$260 56 HOLD

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive FONR Research Pages
FONR Technical Chart FONR Price Prediction FONR Intrinsic Value DCF FONR Earnings Date FONR Investment Advisor FONR Fair Price Analyzer FONR Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals